Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’

The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway

Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia

With this, the company has secured 511 marketing approvals for its oncology products across 66 countries

Parexel appoints Gwyn Bebb to lead oncology clinical development

Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need

Apollo Hospitals appoints Dr. Madhu Sasidhar as Chief Strategy Officer

Jupiter Life Line Hospitals lists at 32.38% premium

The market capitalization of the company stood at Rs. 7,000 crore +

Apollo Telehealth revolutionizes healthcare access through innovation

Apollo Telehealth has established more than 700 centers, in 7 states

Takeda reiterates the need of equitable access to healthcare for universal impact

The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services

RML Hospital inaugurates India’s first dedicated OPD for transgenders

Free Treatment, investigations and sex change surgery along with other facilities will be available at these OPDs for the Transgender community

Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for cell lung cancer

Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial

Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets

Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa